The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Sniffing neuropeptides: a transnasal approach to the human brain
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Born et al. reported that, after giving 40IU (80µg) in man, CSF levels rose within 10min from ~5pg/ml to ~10pg/ml, increasing to ~20pg/ml at 60min (17).”
From Intranasal Oxytocin: Myths and Delusions (2016) · cites this paper as [17]
In the citing paper
“Born et al. achieved plasma concentrations of 20pg/ml after giving 40IU vasopressin (17).These are higher than Robertson et al. reported for any patient, including those with pathologically elevated vasopressin secretion; in man, maximal urine concentrating ability is achieved at a vasopressin concentration of ~5pg/ml (33).”
From Intranasal Oxytocin: Myths and Delusions (2016) · cites this paper as [17]
In the citing paper
“Estimating the CSF volume as 300ml, it seems that ~4.5ng of vasopressin reached the CSF: 0.005% of the given dose -assuming that the rise was due to administered peptide and not endogenous release triggered indirectly.”
From Intranasal Oxytocin: Myths and Delusions (2016) · cites this paper as [17]
In the citing paper
“neuropeptides have been shown to gain access to the brain following intranasal administration (Born et al., 2002;Chang et al., 2012).”
From Sex-specific effects of intranasal oxytocin on autonomic nervous system and emotional responses to couple conflict (2013) · cites this paper as Born et al., 2002
In the citing paper
“Using this delivery route, substantial amounts of insulin are delivered into the brain5”
From Brain insulin action on peripheral insulin sensitivity in women depends on menstrual cycle phase (2023) · cites this paper as [5]
In the citing paper
“The intranasal dose administered in the present study has been associated with changes in central function in humans 58, and similar or smaller doses of oxytocin or vasopressin (24–48 IU for oxytocin; 40–80 IU for vasopressin) have been associated with elevations in peptide levels in the cerebrospinnal fluid in humans or macaques of no more than approximately 55 pg/ml in actual levels 70, 71, 72,”
From The Analgesic Effect of Oxytocin in Humans: A Double‐Blind, Placebo‐Controlled Cross‐Over Study Using Laser‐Evoked Potentials (2016) · cites this paper as [70]
In the citing paper
“Born and colleagues (5) showed that many neuropeptides crossed the blood-brain barrier when given intranasally.”
From Chronic intranasal oxytocin causes long-term impairments in partner preference formation in male prairie voles (2013) · cites this paper as [5]
In the citing paper
“Since it was reported that the intranasal administration of neuropeptides increases their levels in cerebrospinal fluid (Born et al., 2002), there has been an upsurge of interest in experimental manipulations of central oxytocin in human populations (Bartz & Hollander, 2006; Campbell 2010; Heinrichs, von Dawans, & Domes, 2009).”
From Acute intranasal oxytocin improves positive self-perceptions of personality (2012) · cites this paper as Born et al., 2002
In the citing paper
“It is unlikely that the delay had any impact on the results, as previous research has shown that peptide concentrations in the cerebrospinal fluid remain relatively stable even 80 minutes after administration (Born et al., 2002).”
From Acute intranasal oxytocin improves positive self-perceptions of personality (2012) · cites this paper as Born et al., 2002
In the citing paper
“It is unlikely that the delay had any impact on the results, as previous research has shown that peptide concentrations in the cerebrospinal fluid remain relatively stable even 80 minutes after administration (Born et al., 2002).”
From Acute intranasal oxytocin improves positive self-perceptions of personality (2012) · cites this paper as Born et al., 2002
In the citing paper
“The discovery that intranasal administration of neuropeptides can reach the human central nervous system (17)”
From Oxytocin administration to parent enhances infant physiological and behavioral readiness for social engagement (2012) · cites this paper as [17]
In the citing paper
“Intranasal administration of vasopressin (AVP) and of OXT have been reported, in rats and mice, to increase the intracerebral concentration of these peptides, not only in the cerebrospinal fluid but also in selected brain regions (Born et al, 2002;Neumann et al, 2013).”
From Chronic and acute intranasal oxytocin produce divergent social effects in mice (2014) · cites this paper as Born et al, 2002
In the citing paper
“The acute effects of intranasal oxytocin are reported to persist until 60–80 min post-administration.33, 34”
From Oxytocin efficacy is modulated by dosage and oxytocin receptor genotype in young adults with high-functioning autism: a 24-week randomized clinical trial (2016) · cites this paper as [33]
In the citing paper
“It is estimated that only a small amount of intranasally administered oxytocin reaches the brain.33, 34, 46, 47”
From Oxytocin efficacy is modulated by dosage and oxytocin receptor genotype in young adults with high-functioning autism: a 24-week randomized clinical trial (2016) · cites this paper as [33]
In the citing paper
“The direct manipulation of neuropeptidergic central nervous signaling pathways can be achieved via the intranasal administration of peptides, which is known to bypass the blood–brain barrier and result in significant cerebrospinal fluid elevations in substance levels within 40 min, without the need for systemic infusion (14,15).”
From Oxytocin Reduces Reward-Driven Food Intake in Humans (2013) · cites this paper as [14]
In the citing paper
“the exact transnasal-CNS route remains unknown, and the proportion of OXT that actually reaches the CNS is exceptionally small relative to the given dose (Born et al., 2002; Chang et al., 2012; Striepens et al., 2013; Dal Monte et al., 2014; Modi et al., 2014).”
From Marmosets treated with oxytocin are more socially attractive to their long-term mate (2015) · cites this paper as Born et al., 2002
In the citing paper
“These results suggest that intranasal administration rapidly upregulates OT levels in the brain and plasma during the timeframe of behavioral testing, and that OT clears the system several hours after testing.”
From Oxytocin facilitates fidelity in well-established marmoset pairs by reducing sociosexual behavior toward opposite-sex strangers (2014) · cites this paper as Born et al., 2002
In the citing paper
“Intranasally administered insulin is assumed to travel along olfactory and adjacent pathways and has been shown to rapidly accumulate in cerebrospinal fluid, indicating efficient transport to the brain.”
From Intranasal insulin (2021) · cites this paper as [35]
In the citing paper
“When acutely administered to humans at cumulative doses of up to 200 IU, IN insulin does not lead to large increases in systemic concentrations of the hormone 35 and appears to trigger side effects such as increases in cortisol and growth hormone only above this threshold.”
From Intranasal insulin (2021) · cites this paper as [35]
In the citing paper
“Experiments in healthy humans have shown that IN administered insulin bypasses the BBB and is detectable in CSF within 1 hour after administration.”
From Intranasal insulin (2021) · cites this paper as [35]
Citations
Cites
Central nervous system control of food intake
Schwartz, M. W., Woods, S. C., Porte, D., Seeley, R. J., & Baskin, D. G. (2000) · Nature · doi:10.1038/35007534 · Cited by 6,451
Transport of drugs from the nasal cavity to the central nervous system
Illum, L. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00087-7 · Cited by 907
Blood-brain barrier biology and methodology
Pardridge, W. M. (1999) · Journal of NeuroVirology · doi:10.3109/13550289909021285 · Cited by 448
Quantitative analysis of the olfactory pathway for drug delivery to the brain
Thorne, R. G., Emory, C. R., Ala, T. A., & Frey, W. H. (1995) · Brain Research · doi:10.1016/0006-8993(95)00637-6 · Cited by 352
Cerebrospinal Fluid Insulin Levels Increase During Intravenous Insulin Infusions in Man*
Wallum, B. J., Taborsky, G. J., Porte, D., Figlewicz, D. P., Jacobson, L., Beard, J. C., Ward, W. K., & Dorsa, D. M. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-1-190 · Cited by 254
Delivery of Nerve Growth Factor to the Brain via the Olfactory Pathway
Chen, X., Fawcett, J. R., Rahman, Y., Ala, T. A., & Frey, W. H. (1998) · Journal of Alzheimer s Disease · doi:10.3233/jad-1998-1102 · Cited by 247
Central nervous system effects of intranasally administered insulin during euglycemia in men.
Kern, W., Jan Born, A., Schreiber, H., & Fehm, H. (1999) · Diabetes · doi:10.2337/diabetes.48.3.557 · Cited by 192
Self-citationSchwartz, M. W., Bergman, R. N., Kahn, S. E., Taborsky, G. J., Fisher, L. D., Sipols, A. J., Woods, S. C., Steil, G. M., & Porte, D. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115431 · Cited by 183
Vasopressin and Memory Consolidation
de Wied, D., Greidanus, T. B. V. W., Bohus, B., Urban, I. J. A., & Gispen, W. H. (1976) · Progress in brain research · doi:10.1016/s0079-6123(08)60990-5 · Cited by 166
The Melanocortin Melanocyte-Stimulating Hormone/Adrenocorticotropin4–10Decreases Body Fat in Humans1
Fehm, H. L., Smolnik, R., Kern, W., McGregor, G. P., Bickel, U., & Jan Born, A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7298 · Cited by 113
Self-citation
Flagged first, then by citations
Research works printed but not linked: 2
- Strand, F.L. Neuropeptides: Regulators of Physiological Process (MIT Press, Cambridge, 1999).
- Fehm, H.L., Smolnik, R., Kern, W. & Born, J. J. Clin. Endocrinol. Metab. 86, 1144–1148 (2001).
Cited by
Sorted by citations
Items 501–600 of 632
Wingrove, J. O., O’Daly, O., Rubio, A. D. L., Hill, S., Swedroska, M., Forbes, B., Amiel, S. A., & Zelaya, F. O. (2022) · Human Brain Mapping · doi:10.1002/hbm.26019 · Cited by 9
Diabetes and associated cognitive disorders: Role of the Hypothalamic-Pituitary Adrenal axis
Marissal‐Arvy, N., & Moisan, M. (2022) · Metabolism Open · doi:10.1016/j.metop.2022.100202 · Cited by 13
Falling Short: The Contribution of Central Insulin Receptors to Gait Dysregulation in Brain Aging
Case, S. L., Frazier, H. N., Anderson, K. L., Lin, R., & Thibault, O. (2022) · Biomedicines · doi:10.3390/biomedicines10081923 · Cited by 10
Yao, J., He, Z., You, G., Liu, Q., & Li, N. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45080402 · Cited by 9
-Phasic Model of xytocin (): A systematic conceptual review of oxytocin-related ERP research
Pehlivanoglu, D., Myers, E., & Ebner, N. C. (2020) · Biological Psychology · doi:10.1016/j.biopsycho.2020.107917 · Cited by 11
Lowe, S., Sher, E., Wishart, G., Jackson, K., Yuen, E., Brittain, C., Fong, S. C., Clarke, D. O., & Landschulz, W. H. (2017) · Drug Delivery and Translational Research · doi:10.1007/s13346-016-0325-8 · Cited by 10
Radke, S., Jankowiak, K., Tops, S., Abel, T. G., Habel, U., & Derntl, B. (2020) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsaa168 · Cited by 9
Raby, W. N., Heller, M., Milliaressis, D., Choi, C. J., Basaraba, C. N., Pavlicová, M., Alschuler, D. M., LEVIN, F. R., Church, S., & Nunes, E. V. (2021) · Drug and Alcohol Dependence Reports · doi:10.1016/j.dadr.2021.100016 · Cited by 9
GSK-3β Inhibition Affects Singing Behavior and Neurogenesis in Adult Songbirds
Aloni, E., Shapira, M., Eldar-Finkelman, H., & Barnea, A. (2015) · Brain Behavior and Evolution · doi:10.1159/000382029 · Cited by 9
Valdes-Hernandez, P. A., Polk, R. J., Horta, M., Frazier, I. R., Perez, E., Ojeda, M., Porges, E. C., Cruz‐Almeida, Y., Feifel, D., & Ebner, N. C. (2021) · Aging Brain · doi:10.1016/j.nbas.2021.100023 · Cited by 9
Mazura, A. D., & Pietrzik, C. U. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041268 · Cited by 9
Elevated Insulin Levels Engage the Salience Network during Multisensory Perception
Schumann, K., Rodriguez‐Raecke, R., Sijben, R., & Freiherr, J. (2023) · Neuroendocrinology · doi:10.1159/000533663 · Cited by 9
Thompson, R. R., Price, D., Burris, D., Cloutier, A., & Rilling, J. K. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06551-7 · Cited by 7
Neumann, I. D. (2008) · Springer eBooks · doi:10.1007/978-3-540-79288-8_7 · Cited by 8
Quarleri, J. F., & Delpino, M. V. (2022) · GeroScience · doi:10.1007/s11357-022-00528-0 · Cited by 9
Intranasal Drug Delivery to the Brain
Lochhead, J. J., Kumar, N. N., Nehra, G., Stenslik, M. J., Bradley, L. H., & Thorne, R. G. (2022) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-030-88773-5_15 · Cited by 8
A positive effect of intranasal insulin on spatial memory in rats with neonatal diabetes mellitus
Chistyakova, O. V., Бондарева, В. М., Шипилов, В. Н., Sukhov, I. B., & Shpakov, A. O. (2011) · Endocrinology Studies · doi:10.4081/es.2011.e16 · Cited by 8
Diabetes-Related Cognitive Decline, a Global Health Issue, and New Treatments Approaches
Novak, V., Gómez, F., Dias, A. C., Maldonado, D. P., & Alfaro, F. J. (2017) · International Journal of Privacy and Health Information Management · doi:10.4018/ijphim.2017070104 · Cited by 8
Hamidovic, A., Candelaria, L., Rodriguez, I., Yamada, M., Nawarskas, J. J., & Burge, M. R. (2018) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2649 · Cited by 8
Central nervous system-acting agents and the treatment of erectile and sexual dysfunction
Carson, C. C. (2007) · Current Urology Reports · doi:10.1007/s11934-007-0051-3 · Cited by 8
Alfheeaid, H., Alhowail, A., Ahmed, F., Zaki, A., & Alkhaldy, A. (2023) · Brain Science · doi:10.3390/brainsci13020165 · Cited by 11
Hirosawa, T., Kikuchi, M., Okumura, E., Yoshimura, Y., Hiraishi, H., Munesue, T., Takesaki, N., Furutani, N., Ono, Y., Higashida, H., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116918 · Cited by 7
Intranasal Oxytocin Increases Perceptual Salience of Faces in the Absence of Awareness
Xue, S., Wu, H.-B., Zhang, L., & Zhang, D.-X. (2020) · Psychiatry Investigation · doi:10.30773/pi.2019.0130 · Cited by 8
Sustained Treatment with Insulin Detemir in Mice Alters Brain Activity and Locomotion
Sartorius, T., Hennige, A. M., Fritsche, A., & Häring, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162124 · Cited by 7
Kirsch, P., & Meyer-Lindenberg, A. (2010) · The Neurochemical Basis of Autism · doi:10.1007/978-1-4419-1272-5_10 · Cited by 6
Applications of Polymeric Nanoparticle in Nose to Brain Drug Delivery
Sunena, S., Kumar, S., Sulekha, S., Tomar, D., Kumar, D., & Kishore, V. (2023) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2023.00988 · Cited by 6
Cortes, D. S., Skragge, M., Döllinger, L., Laukka, P., Fischer, H., Nilsson, M. E., Hovey, D., Westberg, L., Larsson, M., & Granqvist, P. (2018) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsy068 · Cited by 6
Altinok, D. C. A., Votinov, M., Henzelmann, F., Jo, H., Eisert, A., Habel, U., & Wagels, L. (2021) · Brain Sciences · doi:10.3390/brainsci11121623 · Cited by 6
Edgerton, D. S., Kraft, G., Smith, M. S., Farmer, B., Williams, P. J., & Cherrington, A. D. (2023) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00304.2022 · Cited by 6
Oxytocinergic modulation of speech production—a double-blind placebo-controlled fMRI study
Vogt, C., Floegel, M., Kasper, J., Gispert-Sánchez, S., & Kell, C. A. (2023) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsad035 · Cited by 5
Utility of Downstream Biomarkers to Assess and Optimize Intranasal Delivery of Oxytocin
DuBois, M. C., Tseng, A., Francis, S. M., Haynos, A. F., Peterson, C. B., & Jacob, S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061178 · Cited by 5
Liposomes - Recent Advances, New Perspectives and Applications
Tyagi, R. K. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.102167 · Cited by 5
LEHRER, S., & RHEINSTEIN, P. H. (2023) · In Vivo · doi:10.21873/invivo.13112 · Cited by 5
Nakadate, Y., Kawakami, A., Oguchi, T., Omiya, K., Nakajima, H., Yokomichi, H., Sato, H., Schricker, T., & Matsukawa, T. (2023) · JTCVS Open · doi:10.1016/j.xjon.2023.11.020 · Cited by 7
Perspectives on Treatment of Alzheimer's Disease: A Closer Look into EphB2 Depletion
van Dijken, I., van der Vlag, M., Flores-Hernández, R., & Ross, A. M. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.0214-17.2017 · Cited by 5
Intranasal Insulin Administration Does Not Affect LH Concentrations in Men with Diabetes
Dhindsa, S., Chemitiganti, R., Ghanim, H., Santiago, E., Haider, A., Natalia, C., Mok, M., McKee, A. M., & Dandona, P. (2018) · International Journal of Endocrinology · doi:10.1155/2018/6170154 · Cited by 5
Belokoskova, S. G., Krytskaya, D. V., Beznin, G. V., Karpenko, M. N., & Tsikunov, S. G. (2021) · Medical academic journal · doi:10.17816/maj46393 · Cited by 5
Kis, A., Bolló, H., Gergely, A. E., & Topál, J. (2022) · Animals · doi:10.3390/ani12030296 · Cited by 5
Oxytocin: Vom Geburts- zum Sozialhormon
Steinbach, X., & Maasen, S. (2018) · NTM Zeitschrift für Geschichte der Wissenschaften Technik und Medizin · doi:10.1007/s00048-018-0186-y · Cited by 5
Central Regulation of Glucose Metabolism in Humans: Fact or Fiction?
Gancheva, S., & Roden, M. (2016) · Diabetes · doi:10.2337/dbi16-0032 · Cited by 5
Pharmacokinetics of intranasal drugs, still a missed opportunity?
Sardu, M. L., & Poggesi, I. (2024) · Xenobiotica · doi:10.1080/00498254.2024.2349046 · Cited by 4
Ricchiuti, G., Taillieu, A., Tuerlinckx, E., Prinsen, J., Debbaut, E., Steyaert, J. G., Boets, B., & Alaerts, K. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-06617-6 · Cited by 4
Rash, J. A., Campbell, T. S., Cooper, L., Flusk, D., MacInnes, A. I., Nasr‐Esfahani, M., Mekhael, A. A., Poulin, P. A., Robert, M., & Yi, Y. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-055039 · Cited by 4
Association between salivary oxytocin levels and the amygdala and hippocampal volumes
Shou, Q., Yamada, J., Nishina, K., Matsunaga, M., Matsuda, T., & Takagishi, H. (2022) · Brain Structure and Function · doi:10.1007/s00429-022-02543-5 · Cited by 4
Oxytocin: A developmental journey
Bales, K. L. (2023) · Comprehensive Psychoneuroendocrinology · doi:10.1016/j.cpnec.2023.100203 · Cited by 4
Clarici, A., Bulfon, M., Radin, Y., & Panksepp, J. (2024) · Frontiers in Psychology · doi:10.3389/fpsyg.2024.1395247 · Cited by 6
Bhaskara, B., Dayananda, V. P., Kannan, S., Rao, R. R., & Ramachandraiah, R. (2016) · Indian Journal of Anaesthesia · doi:10.4103/0019-5049.177865 · Cited by 4
Targeting Mediators of Smoking Persistence with Intranasal Insulin
Hamidovic, A. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00706 · Cited by 4
“Less is more”: a dose-response account of intranasal oxytocin pharmacodynamics in the human brainPreprint
Martins, D., Broadmann, K., Veronese, M., Dipasquale, O., Mazibuko, N., Schuschnig, U., Zelaya, F., Fotopoulou, A., & Paloyelis, Y. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.18.427062 · Cited by 7
GSK-3β Inhibition in Birds Affects Social Behavior and Increases Motor Activity
Moaraf, S., Rippin, I., Terkel, J., Eldar-Finkelman, H., & Barnea, A. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.881174 · Cited by 5
Intranasal insulin – effects on the sense of smell
Sienkiewicz-Oleszkiewicz, B., Oleszkiewicz, A., Bock, M. A., & Hummel, T. R. (2023) · Rhinology Journal · doi:10.4193/rhin23.036 · Cited by 4
Zakharova, I. O., Bayunova, L. V., Derkach, K. V., Ilyasov, I. O., Shpakov, A. O., & Avrova, N. F. (2022) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093022020077 · Cited by 4
Martins, D. A., Mazibuko, N., Zelaya, F. O., Vasilakopoulou, S., Loveridge, J., Oates, A., Maltezos, S., Mehta, M. A., Wastling, S. J., Howard, M. A., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/563056 · Cited by 9
Cantero-García, N., Flores‐Burgess, A., Flores-Gómez, M., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1719440 · Cited by 3
Nose-to-Brain Delivery of Peptides and Proteins
Durgun, M. E., Çamlık, G., Değim, İ. T., & Özsoy, Y. (2023) · Springer eBooks · doi:10.1007/978-3-031-23112-4_10 · Cited by 4
The jeong and haan of Vincent van Gogh: neuropeptides of bondedness and loss
Lee, S. W., Cullen, K. R., Rim, S.-R., & Toddes, C. (2024) · Frontiers in Psychology · doi:10.3389/fpsyg.2024.1432175 · Cited by 3
Nasal Oxytocin: Facts and Routes
Lima, J. P. C., & Rodrigues, A. L. (2019) · Acta Psychopathologica · doi:10.4172/2469-6676.100181 · Cited by 3
Dissecting social decision-making: A spotlight on oxytocinergic transmission
Coccia, G., Greca, F. L., Luca, M. D., & Scheggia, D. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1061934 · Cited by 3
Becerra, L. A., Mendez, B., Khan, F. A., Lioutas, V., Novák, P., Mantzoros, C. S., Ngo, L. H., & Novak, V. (2022) · PubMed · Cited by 3
Hypocretin/Orexin Replacement Therapy in Hypocretin/Orexin-Deficient Narcolepsy
Fujiki, N., & Nishino, S. (2006) · Contemporary clinical neuroscience · doi:10.1385/1-59259-950-8:367 · Cited by 3
Insulin Resistance Alzheimer's Disease: Pathophysiology and Treatment
Watson, G. S., & Craft, S. (2007) · Progress in Neurotherapeutics and Neuropsychopharmacology · doi:10.1017/s1748232107000031 · Cited by 3
High‐dose intranasal insulin in an adaptive dose‐escalation study in healthy human participants
Schmitzberger, F., Fowler, J., Hsu, C. H., Pai, M. P., Neumar, R. W., Meurer, W. J., & Silbergleit, R. (2024) · Clinical and Translational Science · doi:10.1111/cts.70071 · Cited by 2
Latva‐Rasku, A., Laurila, S., Karjalainen, T., Klén, R., Löyttyniemi, E., Eskola, O., Nummenmaa, L., Heni, M., & Nuutila, P. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00061.2025 · Cited by 3
Yokoyama, H., Takeda, R., Kawai, E., Ota, A., Morita, E., Imai, D., Suzuki, Y., Morioka, T., Emoto, M., Inaba, M., et al. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7100308 · Cited by 2
Manukyan, A. L., Hunanyan, L. S., Sukiasyan, L. M., Frey, W. H., Yenkoyan, K. B., Danielyan, L., & Melkonyan, M. (2023) · Neurochemical Journal · doi:10.1134/s1819712423040165 · Cited by 2
Yang, M., Yang, G., Lu, T., Cao, L., Xiao, C., Liang, Y., Ding, J., Jiang, X., Wang, W., Chen, F., et al. (2024) · Trials · doi:10.1186/s13063-024-08417-x · Cited by 2
Szymanska, M., Chateau‐Smith, C., Monnin, J., Andrieu, P., Girard, F., Galdon, L., Schneider, M., Pazart, L., Nezelof, S., & Vulliez‐Coady, L. (2016) · JMIR Research Protocols · doi:10.2196/resprot.5643 · Cited by 2
Neurological Manifestations Associated with SARS-CoV-2 Invasion of the Autonomous Nervous System
Poivet, E., Daniel, M., Bozza, F. A., Sharshar, T., & Lledo, P. (2021) · Journal of Cellular Immunology · doi:10.33696/immunology.3.107 · Cited by 2
Maliawan, M. G. D., Subagio, E. A., Utomo, B., Parenrengi, M. A., Fauzi, A. A., & Sudiana, I. K. (2022) · Bali Medical Journal · doi:10.15562/bmj.v11i1.3143 · Cited by 2
Cognitive Enhancers for the Treatment of Anxiety Disorders
Curtiss, J. E., Carpenter, J. K., Kind, S., & Hofmann, S. G. (2016) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780199935291.013.15 · Cited by 2
Numan, M. (2020) · Oxford University Press eBooks · doi:10.1093/oso/9780190848675.003.0008 · Cited by 2
Hormonal Control of Maternal Behavior in Nonhuman Mammals
Numan, M. (2020) · Oxford University Press eBooks · doi:10.1093/oso/9780190848675.003.0003 · Cited by 2
Intranasal delivery of GDNF for the treatment of Parkinson's disease
Migliore, M. M. (2008) · doi:10.17760/d10018463 · Cited by 2
Intranasal GHK peptide enhances resilience to cognitive decline in aging micePreprint
Tucker, M., Keely, A., Park, J. Y., Rosenfeld, M., Wezeman, J., Mangalindan, R., Ratner, D., & Ladiges, W. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.16.567423 · Cited by 1
Intranasal Oxytocin Increases Head Motion During Functional MRI ScanningPreprint
Houlton, S. K., Vaidya, J. G., Breheny, P. J., & Strathearn, L. (2024) · Research Square · doi:10.21203/rs.3.rs-3912105/v1 · Cited by 2
Numan, M. (2020) · Oxford University Press eBooks · doi:10.1093/oso/9780190848675.003.0002 · Cited by 1
Mao, Y., Chen, L., Liu, J. Y., Guo, Z., Lu, P. L., & Chen, Y. X. (2025) · Neuroscience Letters · doi:10.1016/j.neulet.2025.138337 · Cited by 1
REPURPOSING DIABETES DRUGS FOR NEURODEGENERATIVE DISEASES: ANTI-DIABETIC DRUG REPOSITION
Parmar, M., & Panchal, S. S. (2019) · International Research Journal of Pharmacy · doi:10.7897/2230-8407.0912297 · Cited by 1
EFFECT OF KISPEPTIN RECEPTOR BLOCKADE ON BEHAVIORAL INDICATORS OF RATS IN STANDARD TESTS
Tkacheva, M. А., Inyushkina, E. M., Sharafutdinova, A. Y., et al. (2019) · Ulyanovsk Medico-biological Journal · doi:10.34014/2227-1848-2019-1-103-109 · Cited by 1
Anti-Diabetic Drugs Inhibit Bulimia Induced Obesity
Li, Z., Jia, J., Hao, H., Qiao, S., Zhang, Q., Zhang, X., Yu, Q., Sun, X., Wang, K., Gu, R., et al. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2805097 · Cited by 1
Belokoskova, S. G., & Tsikunov, S. G. (2023) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-023-01461-1 · Cited by 1
Nanotechnology-based Nose-to-brain Delivery in Epilepsy: A Novel Approach to Diagnosis and Treatment
Khan, J., & Yadav, S. (2023) · Pharmaceutical Nanotechnology · doi:10.2174/0122117385265554230919070402 · Cited by 1
Li, X., ZHENG, Z., Tian, X., Long, A., Yang, B., Gu, R., Ma, Y., Luo, W., & Feng, C. (2026) · NeuroImage · doi:10.1016/j.neuroimage.2026.121832 · Cited by 1
Bakouie, F. (2018) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2018.09.001818 · Cited by 1
Diffuse Intrinsic Pontine Glioma: Translation of Genomic Knowledge to Clinical Practice
hou, T. Z., Khan, S. A., Firestein, R., Downie, P., & Cain, J. E. (2019) · OBM Neurobiology · doi:10.21926/obm.neurobiol.1901022 · Cited by 1
Central Neural Circuits Regulating Maternal Behavior in Nonhuman Mammals
Numan, M. (2020) · Oxford University Press eBooks · doi:10.1093/oso/9780190848675.003.0005 · Cited by 1
Alloparental Behavior and Paternal Behavior in Nonhuman Mammals
Numan, M. (2020) · Oxford University Press eBooks · doi:10.1093/oso/9780190848675.003.0007 · Cited by 1
Efeito da ocitocina sobre a ansiedade experimental induzida em voluntários saudáveis
Chaves, D. I. (2007) · doi:10.11606/d.60.2007.tde-21052007-100039 · Cited by 1
Intranasal oxytocin enhances intrinsic corticostriatal functional connectivity in womenPreprint
Bethlehem, R. A. I., Lombardo, M. V., Lai, M.-C., Auyeung, B., Crockford, S. K., Deakin, J., Soubramanian, S., Sule, A., Kundu, P., Voon, V., et al. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/068585 · Cited by 7
Kirschbaum, C., & Heinrichs, M. (2006) · Springer eBooks · doi:10.1007/978-3-540-28511-3_7 · Cited by 1
Enhancing Precision in Human NeurosciencePreprint
Nebe, S., Reutter, M., Baker, D. H., Bölte, J., Domes, G., Gamer, M., Gärtner, A., Gießing, C., Mann, C., Hilger, K., et al. (2023) · doi:10.31234/osf.io/m8c4k · Cited by 1
Oxytocin and social learning in socially anxious men and womenPreprint
Flechsenhar, A., Levine, S. M., Müller, L. E., et al. (2023) · doi:10.31234/osf.io/djsa3 · Cited by 1
Intranasal delivery of pGDNF nanoparticles for Parkinson's disease
Harmon, B. T. (2013) · doi:10.17760/d20003327
Comparative social cognition: behavioural, genetic and neurohormonal components
Kis, A. (2014) · Eötvös Loránd Tudományegyetem · doi:10.15476/elte.2014.049
(2003) · Neurology · doi:10.1212/wnl.60.10.1563
Lima, J. P. C. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.47.2018.tde-19042018-161017
Expression of insulin and GLP-1 receptors in interneurons of the cerebral cortex
Csajbók, É. (2019) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.10078
Relações entre ocitocina, apego e sono em pessoas com Transtorno de Ansiedade Generalizada
Vale, E. A. N. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.47.2019.tde-16082019-110304
Metadata
- Authors
- Born, J., Lange, T., Kern, W., McGregor, G. P., Bickel, U., & Fehm, H. L.
- Affiliations
- University of Lübeck (DE)
- Philipps University of Marburg (DE)
- Texas Tech University Health Sciences Center (US)
- Venue
- Nature Neuroscience
- Published
- 2002-05-06
- Volume
- 5
- Issue
- 6
- Pages
- 514-516
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W2086190854
- Cited by
- 1,356
- References
- 14
- Citations by year
- 2026: 25 · 2025: 30 · 2024: 42 · 2023: 48 · 2022: 59 · 2021: 75 · 2020: 61 · 2019: 71 · 2018: 67 · 2017: 72 · 2016: 70 · 2015: 86 · 2014: 110 · 2013: 116 · 2012: 77
- FWCI
- 7.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Keywords
- neuropeptides, intranasal drug delivery, blood-brain barrier bypass, cerebrospinal fluid, ACTH4-10, vasopressin, insulin
- MeSH terms
- Administration, Intranasal, Adrenocorticotropic Hormone, Adult, Brain, Female, Humans, Insulin, Male, Osmolar Concentration, Peptide Fragments, Vasopressins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
